Mirati Therapeutics Inc is a clinical-stage oncology company developing novel therapeutics to address the genetic and immunological promoters of cancer.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Charles M. Baum, M.D.,PhD$4.1B
Market Cap • 23/01/20242013
(há 11 anos)
2013
(11 years ago)
NASDAQ
Listagem
San Diego
Sede • California593
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
MRTXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.